Biggest payout in boxing history may take a big hit in lawsuits

Biggest payout in boxing history may take a big hit in lawsuits
Top Rank, the promoting company that manages Pacquiao, believes it has done no wrong and was “under no obligation to publicly disclose the injury.” We'll see, Top Rank. We'll see. If these class-action lawsuits are found to have merit and make it to …
Read more on Carolinacoastonline

Top Rank Ready To File Suit After Widespread Piracy Of Mayweather-Pacquiao
Top Rank President Todd duBoef said that the company "plans to pursue legal action following widespread piracy of Saturday's Floyd Mayweather-Manny Pacquiao fight on video-sharing smartphone apps and websites," according to Stuart Pfeifer of the L.A. …
Read more on SportsBusiness Daily (subscription)

Tamil Nadu Class 12 Board results: Girls share top rank
S. Mahalakshmi of DAV Higher Secondary School and Sresha C.S. of Velammal Matric Higher Secondary School, Mogappair East are placed together at the top rank. S.Mahalakshmi had Sanskrit as her second language, while Sresha had opted for French.
Read more on India Today

High Court To Consider Lawsuits Over Personal Data

High Court To Consider Lawsuits Over Personal Data
The Supreme Court said Monday it will decide whether Web sites and other firms that collect personal data · Relevant Products/Services can be sued for publishing inaccurate information even if the mistakes don't cause any actual harm. The case is being …
Read more on Top Tech News

CNBC and Inc.Magazine's Iconic Conference Features Chicago's Top Innovators
ENGLEWOOD CLIFFS, NJ & NEW YORK, NY – April 28, 2015 – Some of the country's best-known and most admired entrepreneurs will be speaking, debating and networking at the first iCONIC Conference at The Chicago Theater (175 N. State Street) on …
Read more on CNBC

Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March


New York, New York (PRWEB) April 17, 2015

Testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) that allege this class of prescription medications increases the likelihood that a man will suffer a heart attack, stroke or other life-threatening cardiovascular event continue to mount in a multidistrict litigation underway in U.S. District Court, Northern District of Illinois. According to an updated Statistics Report issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on April 15th, 1,382 cases are now pending in the proceeding. This indicates that 210 new testosterone lawsuits have been filed in the Northern District of Illinois since the Panel issued its previous report on March 16th, when 1,172 cases were noted. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Our Firm is representing clients who have filed testosterone claims in this proceeding, and we continue to receive inquiries from others who were allegedly harmed by testosterone replacement therapy. We do not find it surprising that new cases are being filed in this litigation every month, says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who allegedly experienced dangerous cardiovascular side effects due to low testosterone treatments.

Testosterone Litigation

According to court documents, millions of men have allegedly used testosterone replacement therapies to combat symptoms typically associated with ageing, even though the medications are only approved to treat hypogonadism, a condition in which levels of the hormone drop due to an underlying injury or illness. The federal testosterone litigation underway in Illinois was established by the JPML in June 2014, and initially included only about four dozen cases. The Panels June 6th Order noted that all of the actions had been filed in the wake of the U.S. Food & Drug Administrations (FDA) January 31, 2014 announcement that it was reviewing the cardiovascular risks allegedly associated with testosterone therapy.* On March 3, 2015, the FDA updated its alert, and ordered the manufacturers of prescription testosterone treatments to add new information to their labels regarding the drugs potential to increase a patients risk for heart attacks and strokes. The alert also noted that the labels would be modified to make it clear that such therapy had not been shown safe and effective for relieving symptoms associated with age-related drops in testosterone.

Court records indicate that all of the testosterone lawsuits pending in the federal litigation were filed on behalf of men who allegedly experienced heart attacks, strokes, blood clots and other cardiovascular events due to their use of the medications. The claims accuse the drugs manufacturers of failing to adequately warn patients of these risks, and of wrongly marketing their testosterone therapies as appropriate treatments for low libido, muscle loss, fatigue and other symptoms commonly associated with male aging.

Men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism or other serious cardiovascular events due to their use of low testosterone therapy may be eligible for compensation for medical bills, lost wages and other injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs’ firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

Nearly 1,300 Risperdal Lawsuits Counted in Philadelphia Court Docket, Bernstein Liebhard LLP Reports


New York, NY (PRWEB) February 14, 2015

Nearly 1,300 Risperdal lawsuits (http://www.risperdallawsuit2014.com/) alleging male breast growth and other complications are now pending in a consolidated litigation underway in the Philadelphia Court of Common Pleas, Bernstein Liebhard LLP reports.

According to court documents posted on the Pennsylvania courts website, a total of 1,278 cases are now included in the proceeding, after being filed on behalf of individuals who allege gynecomastia and other complications. Plaintiffs in these cases similarly accuse Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, of failing to adequately warn about side effects that may stem from use of the antipsychotic medication. (In Re: Risperdal Litigation, Case Number 100300296)

We are pleased to see Risperdal lawsuits in Philadelphia continuing to move forward, as our Firm is currently representing numerous individuals whose claims have been filed there. We are actively monitoring updates in the litigation involving this powerful antipsychotic drug, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including Risperdal. The Firm is currently offering free and confidential case evaluations to men and young boys who sustained gynecomastia complications allegedly due to use of Risperdal.

Risperdal Lawsuits

In addition to the number of Risperdal lawsuits now filed in the Philadelphia Court of Common Pleas, court documents indicate that the consolidated litigation is steadily moving forward in other ways. The proceedings first bellwether trial got underway in January 2015 with the opening arguments of a case that alleges complications related to gynecomastia, a condition referring to male breast growth. The plaintiff is a 20-year old autistic man who developed breasts as a child, which coincided with his use of Risperdal. (Case No. 1204-01997)

This litigation is not the first time Johnson & Johnson and Janssen have had to defend claims involving the handling of Risperdal. In November 2013, the companies agreed to pay more than $ 2.2 billion to resolve charges from the U.S. Department of Justice that involved its marketing of this and several other medications. Among other claims filed by the federal government were allegations that Johnson & Johnson and Janssen promoted Risperdal for off-label uses not approved by the U.S. Food and Drug Administration (FDA), which included the treatment of children and elderly patients with dementia.

Among other things, the U.S. Department of Justice (http://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations) had accused the drug makers of improperly promoting Risperdal for off-label uses, including a number of pediatric indications prior to their 2006 FDA approval. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Men and boys who allegedly developed gynecomastia due to treatment with Risperdal may be able to recover compensation for medical bills, lost wages, pain and suffering and other damages. To learn more about Risperdal gynecomastia, please visit Bernstein Liebhard LLPs website. For a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

C.R. Bard and Ethicon Litigations in New Jersey Together Now Include 9,000 Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports


New York, NY (PRWEB) January 19, 2015

More than 9,000 transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) are now pending in New Jersey Superior Court after being filed by women who were allegedly injured by implants manufactured by C.R. Bard Inc. and the Johnson & Johnson subsidiary, Ethicon, Bernstein Liebhard LLP reports.

According to Case Lists updated on January 3rd, more than 7,400 claims are now centralized in the Bergen County litigation established for claims involving Ethicon mesh devices, while another 1,630 have been filed in the C.R. Bard proceeding. These cases allege similar injuries caused by transvaginal mesh implants that were designed to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Women involved in the New Jersey lawsuits accuse both companies of failing to adequately warn about risks associated with their products. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

We are pleased to see continued progress in the New Jersey litigations that currently include thousands of transvaginal mesh lawsuits, as our Firms attorneys are currently representing numerous women who allege injuries caused by implants manufactured by C.R. Bard, Ethicon and several other companies, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free and confidential case evaluations to women who may have been harmed by products manufactured by C.R. Bard, Johnson & Johnsons Ethicon unit, American Medical Systems and Boston Scientific Corp.

Transvaginal Mesh Lawsuits

According to court documents, the nationwide transvaginal mesh litigation has continued to mount since 2008, when the U.S. Food and Drug Administration (FDA) issued its first public health alert that warned about the risk for vaginal mesh complications. The federal regulator categorized the potential for them to occur as rare, a position it augmented three years later after receiving 3,000 adverse event reports from women who alleged mesh erosion and other injuries caused by pelvic implants they received. Following these revelations, the FDA referred to the risk as not rare in a notice issued in July 2011.

Three years later, the FDA took its most recent step in addressing problems with transvaginal mesh by proposing new regulations that would classify the devices as high risk. This would require that manufacturers submit them for rigorous safety testing prior to receiving market approval.*

Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is currently serving as Co-Liaison Counsel for both the C.R. Bard and Ethicon transvaginal mesh litigations in New Jersey. For the Ethicon litigation, Mr. Grand also served on the Plaintiffs trial team for a case that concluded in March 2013 with an $ 11 million ruling in favor of a woman whose Gynecare Prolift implant was found to have caused her injuries.

Mr. Grand is also serving on the Plaintiffs Steering Committees in the following seven separate multidistrict litigations underway in the U.S. District Court, Southern District of West Virginia: (In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2187; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation – MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation – MDL No. 2326; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation – MDL No. 2327; Coloplast Corp. Pelvic Support Systems Products Liability Litigation – MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation – MDL No. 2440; and In Re: Neomedic Pelvic Repair System Products Liability Litigation – MDL No. 2511.)

Women who allege serious complications of transvaginal mesh may be eligible to receive compensation for lost wages, medical bills, pain and suffering and other injury-related damages. Learn more about filing a lawsuit through a transvaginal mesh attorney at Bernstein Liebhard LLP by visiting the Firms website, or Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.

*http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm395192.htm, U.S. Food and Drug Administration (FDA), April 29, 2014.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

Judge In DePuy ASR Hip Recall Lawsuits Extended Deadline For Hip Recipients, Reports Wright & Schulte LLC


Columbus, OH (PRWEB) January 11, 2015

The judge presiding over the federal litigation of DePuy ASR hip recall lawsuits has issued an order extending the deadline to January 31 for DePuy ASR hip implant plaintiffs who have not undergone revision surgery to decide whether to dismiss their case or continue with their ASR hip replacement lawsuit. Judge Katz issued an order in October allowing non-revision ASR hip implant plaintiffs to submit a form by December 31 that specifies whether they will continue or dismiss their case. According to the order, plaintiffs who elect to dismiss their case may file their DePuy ASR Hip recall lawsuits again if they require revision surgery in the future. DePuy has agreed to toll, or suspend, the statute of limitations in those cases, Judge Katz said in his order. The plaintiffs newly filed DePuy ASR complaint will be considered a continuation of their previously filed DePuy ASR lawsuit, according to the judges order. Judge Katz issued an order on December 24 to extend the election deadline to January 31. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation MDL 2197)

The firm is currently representing numerous clients from around the country in DePuy Hip recall lawsuits and continues to off free legal evaluations to DePuy hip replacement recipients. To speak with one of the attorneys at Wright & Schulte LLC call 1-800-399-0705 or visit http://www.yourlegalhelp.com for more information on this and other hip replacement lawsuit news.

DePuy issued a recall of its ASR total hip system in August 2010 after data showed that the revision rates within five years was about 13 percent, according to the U.S. Food and Drug Administration (FDA). The FDA notes that metal-on-metal implant systems carry unique risks because metal can be released from parts of the implants as the patient walks or run. Over time, some of the metal ions (cobalt and chromium) from the implant or from the metal particles can enter a hip recipients bloodstream. The metal particles can also lead to damage to the bone or tissue that is near the implant and joint. This adverse local tissue reaction due to the metal debris may lead to pain, implant loosening, device failure, and the need for removing the implant and replacing it with another one.

[fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm, January 17, 2013]

Court records for the U.S. District Court, Northern District of Ohio indicate that there are 7,761 DePuy ASR Hip Implant product liability lawsuits pending as of December 15, 2014. The DePuy ASR hip recall lawsuits allege that the DePuy ASR hip systems were defectively designed and that Johnson & Johnson and DePuy did not adequately warn patients and health providers of its risk. The DePuy ASR hip complaints further allege that metal debris released from the hip implants metal components caused plaintiffs to suffer such serious health complications as metallosis (metal poisoning), chromium and cobalt poisoning, swelling, and pain which resulted in early failure of the implant and in some cases, a need for revision surgery. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation MDL 2197)

Bloomberg reported in October 2013 that DePuy agreed to pay nearly $ 2.5 billion to settle about 8,000 DePuy ASR hip recall lawsuits lawsuits with plaintiffs who had surgery to remove DePuys ASR metal-on-metal hip implants as of August 31, 2013. According to Bloomberg, the plaintiffs who had the revision surgery would receive an average base settlement award of $ 250,000. The agreement also called for plaintiffs who underwent multiple revision surgeries to receive a supplemental award.

[bloomberg.com/news/2014-10-30/j-j-may-pay-250-million-to-settle-1-000-more-hip-claims.html, October 30, 2014]

About Wright & Schulte LLC And Filing A Depuy ASR Hip Recall Lawsuit

Wright & Schulte LLC, an experienced defective medical device firm, is dedicated to the belief that Americas legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure those rights. If youre looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free DePuy ASR Hip Lawsuit Settlement case evaluations are available through yourlegalhelp.com, or call 1-888-365-2602.

Contact:

Wright & Schulte LLC

812 East National Road

Vandalia, Ohio 45377

1-800-399-0795

http://www.yourlegalhelp.com

Like us on Facebook

Follow us on Twitter

Join us on Google+







Nearly 2,000 Federally-Filed Biomet Hip Lawsuits Continue to Await Review in Illinois MDL, Bernstein Liebhard LLP Reports


New York, NY (PRWEB) December 14, 2014

More than 1,900 Biomet hip lawsuits (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) remain in a multidistrict litigation now underway in Indiana federal court, Bernstein Liebhard LLP reports.

Court documents on December 9th state that 1,938 lawsuits that allege similar injuries caused by the Biomet M2a Magnum Hip Implant are now pending in the federal proceeding, which is continuing to move forward in the U.S. District Court, Northern District of Indiana. According to recent records, the current number of cases is smaller than it was in July, when parties estimated that 2,300 claims had been filed. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation MDL No. 2391)

We are representing numerous individuals in the federal Biomet hip litigation, and we continue to field inquiries from recipients of the M2a Magnum hip, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal consultations to individuals who may have been injured by metal-on-metal hip implants, including the Biomet M2a Magnum Hip Replacement System.

Biomet Hip Lawsuits

Court documents show that Biomet cases now pending in the U.S. District Court, Northern District of Indiana were filed on behalf of individuals who allege metallosis, pseudotumor formation, chronic pain and other complications due to the metal-on-metal design of the M2a Magnum hip. At the beginning of this year, the Court granted approval for a proposed settlement of Biomet hip lawsuits, which would resolve hundreds of cases if it became finalized. Under the terms of the settlement, which were announced on February 3, 2014, plaintiffs who underwent revision surgery to remove the M2a Magnum hip after it was implanted more than 180 days after originally receiving the implant would be granted a base award of $ 200,000. The Biomet settlement would need to be accepted by 90% of eligible plaintiffs in order to be accepted, according to court records.

A little over a year before the Biomet settlement was announced, a public health alert from the U.S. Food and Drug Administration (FDA) warned that metal-on-metal implants were more likely to fail early than those made of other materials. All patients who received this kind of hip replacement device should undergo routine metal ion blood testing to monitor for signs that their hip is failing, the agency said in January 2013.

Individuals who received the Biomet M2a Magnum hip may be entitled to compensation for damages related to the formation of pseudotumors, chronic pain, premature device failure or another injury allegedly due to the hips metal-on-metal design. Learn more about the litigation involving Biomet hip replacements and other metal-on-metal hip implants by visiting Bernstein Liebhard LLPs website. To arrange for a free case review, call 800-511-5092 to speak with a member of our legal staff.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) November 28, 2014

Mirena lawsuits (http://www.mirenalawsuit2014.com/ ) are continuing to move forward in New Jerseys Bergen County Superior Court, where the number of claims in a consolidated litigation established there is quickly approaching 1,300, Bernstein Liebhard LLP reports. A Case List updated on November 18th shows 1,293 lawsuits now pending in the consolidated proceeding, which was created for lawsuits that allege complications resulting from spontaneous migration of the birth control IUD. Plaintiffs in these cases similarly accuse its manufacturer, Bayer Healthcare Pharmaceuticals, of failing to properly warn women about the contraceptives potential to move away from its original point of insertion in the uterus and into other parts of the body. (In Re: Mirena Litigation; Case No. 297)

Our Firm is representing a number of women who were allegedly harmed by Mirena. We are not surprised to see the number of Mirena IUD lawsuits filed in New Jerseys Bergen County continuing to increase, says Bernstein Liebhard LLP, a nationwide law firm representing women involved in the consolidated litigation who were allegedly harmed by the IUD. The Firm is currently offering free and confidential case evaluations to women who claim to have suffered complications following spontaneous migration of the device.

Mirena Lawsuits

The Mirena IUD was approved as a method of birth control in 2000 by the U.S. Food and Drug Administration (FDA). Referred to as a long-acting contraceptive (LARC), the device is inserted into the uterus by a healthcare provider and emits a low dose of the synthetic progestin, levonorgestrel for up to five years. In 2009, the agency expanded Mirenas list of approved uses to include the treatment of heavy menstrual bleeding in women who use an IUD as their primary method of birth control.*The FDA issued a Warning Letter to Bayer that same year that found certain Mirena promotions be misleading.

In addition to the consolidated Mirena litigation now underway in Bergen County Superior Court, where the attorneys at Bernstein Liebhard LLP are actively filing cases, court documents in a federal litigation established in New York show a total of 1,089 claims. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)

Women who were allegedly injured by Mirena may be eligible to receive compensation for out-of-pocket medical expenses, lost wages, pain and suffering and more. Learn more about filing a Mirena lawsuit when you visit Bernstein Liebhard LLPs website, or the Firms Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.

*http://www.fda.gov/newsevents/newsroom/pressannouncements/2009/ucm184747.htm, FDA, October 2009

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports


New York, New York (PRWEB) November 28, 2014

More than 2,100 Stryker hip lawsuits (http://www.consumerinjurylawyers.com/stryker-rejuvenate/stryker-hip-lawsuits/) have now been filed in a New Jersey litigation that involves a pair of recalled metal implants, Bernstein Liebhard LLP reports.

A Case List updated on November 18th in Bergen County Superior Court reflects the filing of 2,160 claims over the Rejuvenate and ABG II modular-neck hip stems, which were voluntarily recalled on July 6, 2012 by their manufacturer, Stryker Orthopaedics. Plaintiffs in these lawsuits allege pain, swelling, a loss of mobility and symptoms associated with metallosis (metal ion poisoning) caused by the implants, which they claim to have been inadequately warned about prior to their being taken off the market. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

We are not surprised to see additional lawsuits continuing to be filed in New Jerseys metal hip litigation, as we continue to hear from clients who need to have their Rejuvenate and/or ABG II modular-neck hip stems revised, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to potential plaintiffs in Stryker recall lawsuits.

Stryker Hip Litigation

Before the New Jersey Stryker litigation issued its most recent update, the court announced a settlement that could resolve thousands of claims filed in state and federal courts over the recalled Rejuvenate and ABG II implants. According to documents released on November 3rd, the global settlement program provides for base awards of $ 300,000 per failed implant, which could vary depending on complications suffered during revision surgery, and other damages that may include future surgeries caused by the complications. Claimants who are medically unable to undergo revision surgery but need to do so will also be provided damage awards through the agreement, which will likely be received by the summer of 2015, the documents stipulate. All Stryker lawsuits in this litigation were filed after the 2012 recall, and similarly allege fretting and corrosion of the Rejuvenate and ABG II devices metal components.

In addition to Stryker recall claims filed in New Jersey, thousands of others have also been centralized in a federal multidistrict litigation established in the U.S. District Court, District of Minnesota. A Case List updated on November 17th shows that 2,179 cases have now been filed in the proceeding. Counsel involved in this proceeding are also signatories to the Stryker hip settlement agreement. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

Rejuvenate and ABG II hip stem recipients may be eligible for compensation if they experienced complications related to the Stryker hip recall. To learn more, please visit Bernstein Liebhard LLPs website. To arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

800-511-5092

ATTORNEY ADVERTISING.

Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following Chinas Rejection of Corn Shipments Tainted with Unapproved GMO Seed


Columbus, OH (PRWEB) November 23, 2014

Syngenta lawsuits are now being investigated by Wright & Schulte LLC on behalf of farmers and agribusinesses that have allegedly incurred significant financial damages due to Syngenta, Inc.s attempts to commercialize Agrisure Viptera and Agrisure Duracade, genetically modified (GMO) corn seed products that have not been approved for sale in China. According to a report from Bloomberg News, Syngentas actions have caused China to virtually ban U.S. corn imports. Because China is the third-largest American corn importer, Syngenta GMO lawsuit plaintiffs claim prices have crashed, costing farmers and agribusinesses more than $ 1 billion.

[bloomberg.com/news/2014-10-30/syngenta-modified-strain-ruined-corn-market-farmers-claim-1-.html, Bloomberg News, October 30, 2014]

Wright & Schulte LLC is offering free legal consultations to commercial corn growers, harvesters and sellers who were financially harmed by Syngentas actions. For more information on filing a Syngenta GMO corn seed lawsuit, or to arrange for a free legal review, call 1-800-399-0795 or visit yourlegalhelp.com.

According to a report that appeared in The Wall Street Journal on September 12th, Agrisure Viptura, also known as MIR 162, was developed by Syngenta to produce a protein that makes plants pest resistant. While the company applied to Chinese regulators for approval of the GMO seed, the product has not been cleared for sale in that country. Since November 2013, China’s government has rejected more than one million metric tons of corn destined for Chinese buyers, and prices have plunged more than 60% from their 2012 peak.

[online.wsj.com/articles/cargill-sues-syngenta-says-gmo-seed-sales-hurt-u-s-corn-exports-to-china-1410542784?KEYWORDS=Syngenta, Wall Street Journal, September 12, 2014]

Over the past several months, Syngenta GMO corn seed lawsuits have begun to mount in courts around the country. Most recently, a group of farmers filed a class action lawsuit in U.S. District Court, Northern District of Illinois, alleging that because Syngentas GMO seed varieties constitute 3 percent of U.S.-planted acreage, theres no way to ensure that corn for export wont contain trace quantities. The complaint seeks to benefit anyone in the U.S. who grew, harvested or sold non-modified corn in the past year. (Case No. 14-cv-8556)

Cargill, Inc. and Trans Coastal Supply Co. each filed Syngenta lawsuits over the companys handling of Agrisure Viptura. Trans Coastal, which filed its complaint in the U.S. District Court, Central District of Illinois on September 16th , alleges that Syngentas actions could ultimately cost it as much as $ 141 million. (Case No. 2:14-cv-02221-CSB-DGB) Cargill, which filed suit in Louisianas 40th Judicial District Court on September 12th, claims the commercialization of the GMO seed has exposed it to $ 90 million in losses. (Case No. 60671)

Court records indicate that these cases are among nearly a dozen Syngenta GMO corn seed lawsuits now pending in U.S. courts. Plaintiffs in these claims have petitioned the U.S. Judicial Panel on Multidistict Litigation to consolidate all federally-filed claims involving similar allegations in a single court for coordinated pretrial proceedings. The Panel is scheduled to hear oral arguments on the matter on December 4th. (In Re: Syngenta AG MIR 162 Corn Litigation MDL No. 2591)

About Wright & Schulte LLC

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that Americas legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the worlds most powerful corporations take responsibility for their actions. If youre looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Syngenta GMO corn seed lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:

Wright & Schulte LLC

812 East National Road

Vandalia, Ohio 45377

1-800-399-0795

http://www.yourlegalhelp.com

Like us on Facebook

Follow us on Twitter

Join us on Google+